| Scientific Name |
Crizotinib
|
|---|---|
| Brand Name |
Xalkori
|
| Risk |
•Breathing problems associated with interstitial lung disease and pneumonitis. •Light-headedness, fainting, chest discomfort or irregular heartbeat associated with bradycardia, QT prolongation and cardiac failure. • Abnormalities in liver blood tests associated with hepatotoxicity. • Visual changes, including guidance to assess visual symptoms in the paediatric population. • Stomach disorders associated with gastrointestinal perforation.
|
| Educational Materials for Patients |
|